Every 10-Q that Pineapple Financial Inc. (PAPL) has filed with the SEC in the last 24 months is listed below, newest first, and each one links through to the document itself with the summary and the scores our analysis gives it.
A 10-Q covers the quarterly report filed between annual reports, so if you follow PAPL and want that one kind of document rather than the whole filing history, this is the page to keep. The company's other filings, of every form, are on the full PAPL filings page.
Pineapple Financial Inc., a Canadian mortgage and digital asset company listed on NYSE American, reported net income of 25,250,083 for the three months ended May 31, 2026, versus a prior-year loss. Mortgage-related revenue was 622,502, while a 25,824,284 fair value gain on Injective tokens and 399,134 of staking income drove the quarterly profit. For the nine months, revenue totaled 2,052,335 and the company recorded a net loss of 1,346,969 (basic and diluted loss per share of 0.09).
Total assets rose to 75,853,112, dominated by 49,400,549 of digital assets and 12,002,619 of related-party loans receivable. Funding includes 21,442,877 of loans payable, notably 19,440,258 outstanding under a FalconX credit facility secured by about 7,303,725 Injective tokens (fair value 47,719,617) and 5,424,320 of restricted cash. Shareholders’ equity increased to 51,619,305 after a January 6, 2026 PIPE issuing 24,642,700 shares for 21,949,955 in cash and 31,323,740 in digital assets, partly offset by repurchasing 554,581 shares for 648,805.
Operating activities used 4,621,408 of cash over nine months, while financing and investing activities provided 39,965,754 and used 26,859,283, leaving cash and restricted cash of 10,514,027. With an accumulated deficit of 14,743,408, continuing operating losses and negative operating cash flows, management states that these conditions, alongside reliance on volatile digital asset values and secured borrowing, raise substantial doubt about the company’s ability to continue as a going concern within one year, despite planned cost controls, staking income and potential additional financing.
Pineapple Financial Inc. (PAPL) reports a sharply higher net loss driven by its new crypto strategy and financing costs. For the six months ended February 28, 2026, the company generated revenue of $1.4 million, slightly below the prior year, mainly from Canadian mortgage brokerage, subscriptions, insurance and related services.
Net loss widened to $25.9 million from $1.3 million, largely due to a $23.0 million non-cash fair value loss on digital assets and $3.3 million of financing-related costs, including warrant and equity line of credit expenses and higher interest on new borrowings. The company deployed $45.4 million into Injective (INJ) and other digital assets, which are now carried at $22.4 million after market-driven write-downs.
Cash increased to $17.7 million, supported by a January 2026 PIPE that raised $21.9 million in cash and $31.3 million in digital assets, and by a $19.0 million secured loan from FalconX at 10% interest. Despite $3.1 million of positive working capital, management discloses substantial doubt about the company’s ability to continue as a going concern, citing recurring losses and negative operating cash flows, even as it pursues cost reductions, staking income and liquidity initiatives.
Pineapple Financial Inc. reported a sharp deterioration in results for the three months ended November 30, 2025, and flagged substantial doubt about its ability to continue as a going concern. Revenue slipped to $721,727 from $766,074, while mortgage volume rose to $457.1M, showing higher activity but weaker net economics.
The company posted a net loss of $6,435,085 versus $656,894 a year earlier, mainly from a $6,140,379 non‑cash fair value loss on Injective crypto assets, whose value fell to $5,764,245 from an $11,896,002 cost base. Operating expenses excluding this loss declined as selling, marketing, and salary costs were cut.
As of November 30, 2025, Pineapple had negative shareholders’ equity of $(5,488,511), an accumulated deficit of $19,831,524, and a working capital deficit of $13,003,160. It also carried an $11,983,087 FalconX loan classified as current. Subsequent to quarter‑end, the company closed a $100M equity financing linked to the Injective initiative, received about $19.0M in cash, and repaid the FalconX loan.